Reduction of allodynia by intrathecal transplantation of microencapsulated porcine chromaffin cells.

Bovine chromaffin cells (BCCs) are well known to have analgesic effect to reduce acute or chronic pain when transplanted in the subarachnoid space and have been considered as an alternative therapy for pain management. However, due to recent concerns over risks associated with prion transmission, porcine tissue is considered to be an alternate xenogeneic source for clinical use. In the present study, we investigated whether microencapsulated porcine adrenal medullary chromaffin cells (PCCs) also have analgesic effect to reduce allodynia caused by neuropathic pain in chronic constriction injury model of rat. PCCs were isolated from a porcine adrenal medulla and then microencapsulated with alginate and poly. In in vitro tests, the microencapsulated PCCs were investigated whether they have an ability to release catecholamines responding to nicotine stimulation. The levels of catecholamines released from the microencapsulated PCCs were significantly higher than from microencapsulated BCCs. In addition, the microencapsulated PCCs released catecholamines and met-enkephalin responding to cerebral spinal fluid (CSF) retrieved from a neuropathic pain model. In in vivo tests, implantation of microencapsulated PCCs reduced both mechanical and cold allodynia in chronic constriction injury model of a rat whereas the microencapsulated BCCs reduced only cold allodynia under the same conditions. The injection of antagonist of opioid peptides reversed the reduction of cold allodynia in microencapsulated PCC-received animal. The levels of catecholamines in the CSF of rats after implantation of microencapsulated PCCs were significantly higher than in the control group. These data suggest that microencapsulated PCCs may be another effective source for the treatment of neuropathic pain.

[1]  E. Ancona,et al.  Xenotransplantation-current status and future perspectives. , 2005, British medical bulletin.

[2]  Jeong-Ok Lim,et al.  Immunoisolated chromaffin cells implanted into the subarachnoid space of rats reduce cold allodynia in a model of neuropathic pain: a novel application of microencapsulation technology. , 2004, Artificial organs.

[3]  Ying Lu,et al.  Porcine chromaffin cells, culture, and transplant for antinociceptive effects in rodents and primates , 2004, Neurological research.

[4]  C. Mascott,et al.  Intrathecal xenogeneic chromaffin cell grafts reduce nociceptive behavior in a rodent tonic pain model , 2004, Experimental Neurology.

[5]  M. Hoane,et al.  No detectable analgesic effects in the formalin test even with one million bovine adrenal chromaffin cells , 2002, PAIN.

[6]  A. D'apice,et al.  Xenotransplantation: past achievements and future promise. , 2002, Heart, lung & circulation.

[7]  M. D. Lindner,et al.  Numerous adrenal chromaffin cell preparations fail to produce analgesic effects in the formalin test or in tests of acute pain even with nicotine stimulation , 2000, Pain.

[8]  I. Hentall,et al.  Spinal CSF from rats with painful peripheral neuropathy evokes catecholamine release from chromaffin cells in vitro , 2000, Neuroscience Letters.

[9]  C. Tsai,et al.  Temperature affects the development of central neurotransmitter systems of tilapia, Oreochromis mossambicus , 2000, Neuroscience Letters.

[10]  I. Hentall,et al.  The alleviation of pain by cell transplantation. , 2000, Progress in brain research.

[11]  E. Buchser,et al.  Intrathecal implants of bovine chromaffin cells alleviate mechanical allodynia in a rat model of neuropathic pain , 1998, Pain.

[12]  Y. Lazorthes,et al.  Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centers. , 1997, Neurological research.

[13]  P. Aebischer,et al.  Immunoisolated Xenogeneic Chromaffin Cell Therapy for Chronic Pain: Initial Clinical Experience , 1996 .

[14]  Choi Yoon,et al.  Behavioral signs of ongoing pain and cold allodynia in a rat model of neuropathic pain , 1994, Pain.

[15]  L. Christenson,et al.  Transplantation of Encapsulated Bovine Chromaffin Cells in the Sheep Subarachnoid Space: A Preclinical Study for the Treatment of Cancer Pain , 1994, Cell transplantation.

[16]  A. Hama,et al.  Alleviation of neuropathic pain symptoms by xenogeneic chromaffin cell grafts in the spinal subarachnoid space , 1994, Brain Research.

[17]  T. Yaksh,et al.  Quantitative assessment of tactile allodynia in the rat paw , 1994, Journal of Neuroscience Methods.

[18]  J. Sagen,et al.  Adrenal medullary implants in the rat spinal cord reduce nociception in a chronic pain model , 1990, Pain.

[19]  Gary J. Bennett,et al.  A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man , 1988, Pain.

[20]  H. Pollard,et al.  Analgesia induced by isolated bovine chromaffin cells implanted in rat spinal cord. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Livett.  Adrenal medullary chromaffin cells in vitro. , 1984, Physiological reviews.

[22]  J. Haycock,et al.  Bovine adrenal chromaffin cells: high-yield purification and viability in suspension culture , 1983, Journal of Neuroscience Methods.